Antony A. Cooper

UNSW Sydney — Australia

Medicine · Health Sciences

30h-index6.3kcitations65works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(25), Cellular transport and secretion(13), Fungal and yeast genetics research(12), Alzheimer's disease research and treatments(8), RNA Research and Splicing(8)

Publications64 total

Replication-first reciprocal genome editing resolves ANKRD1 as a convergent regulatory target at the 17q21.31 locus
2026Open Access
Inherited Genetic Variation in Parkinson’s Disease: Convergence on Impaired Autophagosome-Lysosome Fusion Through the Altered Expression of mRNA Isoforms
Molecular Neurobiology·2025· 1 citedOpen Access
FAMILY-BASED RNA SEQUENCING IN BIPOLAR DISORDER FOR CANDIDATE GENE AND PATHWAY IDENTIFICATION
2025Open Access
From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease
Journal of Parkinson s Disease·2025· 2 citedOpen Access
Future is now: an Australasian perspective on disease-modifying trials in Parkinson’s and prodromal disease
BMJ Neurology Open·2025· 1 citedOpen Access
Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies
2024· 3 citedOpen Access
Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay
npj Parkinson s Disease·2024· 10 citedOpen Access
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
npj Parkinson s Disease·2024· 8 citedOpen Access
Fine-mapping identifies 27 allele-specific MPRA regulatory variants in Parkinson’s disease related loci
Research Square (Research Square)·2023Open Access
F45. RNA SEQUENCING ANALYSES IN BIPOLAR MULTIPLEX FAMILIES POINT TO NOVEL GENES AND DYSREGULATED PATHWAYS
European Neuropsychopharmacology·2023
F37. STUDY OF ALTERNATIVE SPLICING EVENTS IN MULTIPLEX BIPOLAR FAMILIES
European Neuropsychopharmacology·2023
Identifying the genetic links between Parkinson’s disease and non-motor symptoms: novel insights into disease mechanisms
Research Square (Research Square)·2023· 1 citedOpen Access
Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
Scientific Reports·2023· 1 citedOpen Access
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Scientific Reports·2023· 33 citedOpen Access
Identifying robust and reliable volatile organic compounds in human sebum for biomarker discovery
Analytica Chimica Acta·2022· 15 cited
Redefining the hypotheses driving Parkinson’s diseases research
npj Parkinson s Disease·2022· 26 citedOpen Access
Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay
ACS Chemical Neuroscience·2022· 19 citedOpen Access
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
Genes & Diseases·2022· 18 citedOpen Access
The Role of Clinical Medicine
Drug repurposing·2022· 1 cited
Establishing gene regulatory networks from Parkinson’s disease risk loci
Brain·2022· 20 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Justin M. O’Sullivan(11), Sophie Farrow(10), Kathryn J. Hill(8), William Schierding(7), Glenda M. Halliday(6), Boris Guennewig(6), Tayaza Fadason(5), Sreemol Gokuladhas(5), Susan Lindquist(4), Tom H. Stevens(4), Howard Bussey(4), Aaron D. Gitler(3), Cole M. Haynes(3), Katherine E. Strathearn(3), Kim A. Caldwell(3), Guy A. Caldwell(3), Jean‐Christophe Rochet(3), Karen E. Murphy(3), Amanda M. Gysbers(3), Clemens R. Scherzer(3)